Journal Says Ivermectin Study Met Standard for 'Credible Science'
The new ivermectin paper immediately drew flak on social media, including from Gideon Meyerowitz-Katz, who described a number of weaknesses in the work, starting with the inaccurate title.
Brian Wansink John Adler Jr Gideon Meyerowitz Katz Flavio Cadegiani Pierre Kory Critical Care Alliance
Source: medscape.com